Alternative splice variant of actinin-4 in small cell lung cancer

被引:45
作者
Honda, K [1 ]
Yamada, T [1 ]
Seike, M [1 ]
Hayashida, Y [1 ]
Idogawa, M [1 ]
Kondo, T [1 ]
Ino, Y [1 ]
Hirohashi, S [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Canc Proteom Project, Chuo Ku, Tokyo 1040045, Japan
关键词
actin; actinin-4; alternative splicing; cancer-testis antigen; small-cell lung cancer;
D O I
10.1038/sj.onc.1207652
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor-associated alternative RNA splicing has gained considerable attention. We identified a novel alternative splice variant RNA of actinin-4 in human small cell lung caner (SCLC). Expression of the splice variant was highly specific to SCLC cell lines (10/10), biopsies (3/3), and testis. The variant encoded a peptide with a three amino-acid change in exon 8, where the germline missense mutation takes place in familial focal segmental glomerulosclerosis (FSGS). The variant protein showed high affinity to filamentous actin polymers and was not localized with cortical actin. Alternatively spliced actinin-4 may be a new diagnostic marker of SCLC and a candidate target for selective therapy.
引用
收藏
页码:5257 / 5262
页数:6
相关论文
共 16 条
[1]  
Araki N, 2000, J CELL SCI, V113, P3329
[2]   Significance of cytologic criteria in distinguishing small cell from non-small cell carcinoma of the lung [J].
Arora, VK ;
Singh, N ;
Chaturvedi, S ;
Bhatia, A .
ACTA CYTOLOGICA, 2003, 47 (02) :216-220
[3]  
Behrens J, 1992, Semin Cell Biol, V3, P169
[4]  
CARNEY DN, 1985, SEMIN ONCOL, V12, P289
[5]   The spectrin repeat:: a structural platform for cytoskeletal protein assemblies [J].
Djinovic-Carugo, K ;
Gautel, M ;
Ylänne, J ;
Young, P .
FEBS LETTERS, 2002, 513 (01) :119-123
[6]  
dos Santos NR, 2000, CANCER RES, V60, P1654
[7]  
Echchakir H, 2001, CANCER RES, V61, P4078
[8]   Cell adhesion system and human cancer morphogenesis [J].
Hirohashi, S ;
Kanai, Y .
CANCER SCIENCE, 2003, 94 (07) :575-581
[9]   Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion [J].
Honda, K ;
Yamada, T ;
Endo, R ;
Ino, Y ;
Gotoh, M ;
Tsuda, H ;
Yamada, Y ;
Chiba, H ;
Hirohashi, S .
JOURNAL OF CELL BIOLOGY, 1998, 140 (06) :1383-1393
[10]   CTL-defined cancer vaccines:: Perspectives for active immunotherapeutic interventions in minimal residual disease [J].
Jäger, E ;
Jäger, D ;
Knuth, A .
CANCER AND METASTASIS REVIEWS, 1999, 18 (01) :143-150